Next Article in Journal
Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging
Next Article in Special Issue
Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates Administered via Subcutaneous and Intratumoral Routes
Previous Article in Journal
Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
Previous Article in Special Issue
Implementation of Systematic Bioanalysis of Antibody–Drug Conjugates for Preclinical Pharmacokinetic Study of Ado-Trastuzumab Emtansine (T-DM1) in Rats
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(3), 915; https://doi.org/10.3390/pharmaceutics15030915
Action Date Notes Link
article pdf uploaded. 11 March 2023 10:12 CET Version of Record https://www.mdpi.com/1999-4923/15/3/915/pdf-vor
article xml uploaded. 13 March 2023 09:05 CET Original file https://www.mdpi.com/1999-4923/15/3/915/xml
article pdf uploaded. 13 March 2023 09:05 CET Updated version of record https://www.mdpi.com/1999-4923/15/3/915/pdf
article html file updated 13 March 2023 09:07 CET Original file -
article html file updated 20 March 2023 22:33 CET Update https://www.mdpi.com/1999-4923/15/3/915/html
Back to TopTop